Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of oral L-carnitine on echocardiography of dialysis patients
IRCT20230425057989N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levocarnitine in pulmonary hypertension (PH), sponsored by Shahrekord University of Medical Sciences. Primary endpoint: Change in echocardiographic parameters. Started May 2023; status: completed.
02
Drugs
levocarnitine
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on IRCT20230425057989N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230425057989N1.